Acucela Announces Experimental Eye Research Publication; Paper Outlines First Demonstrated Effect of Visual Cycle Modulation Treatment on Retinopathy

Dr. Ryo Kubota, Acucela President and CEO, a Co-Author with
Colleagues at Children's Hospital and Harvard Medical of These
Significant Findings
BOTHELL, Wash.--(BUSINESS WIRE)--Aug 9, 2010 - Acucela, a
clinical-stage biotechnology company...

...

More on Sciencestage.com

    More on Wikipedia

      Related Videos

        More on answers.yahoo.com

          More on Pubmed

            More on Answers.com